Market Place
Sourcing Support
TrialSpark Rebrands as Formation Bio
05 Dec 2023 //
PR NEWSWIRE
TrialSpark doses first patient in Phase II trial of AD therapy
24 May 2023 //
CLINICAL TRIALS ARENA
TrialSpark Announces First Patient Dosed in Phase 2 Trial for ASN008-201
23 May 2023 //
PR NEWSWIRE
Sanofi inks deal with TrialSpark to find new drugs to acquire
07 Oct 2022 //
FIERCEBIOTECH
Paul Hudson & TrialSpark`s desire to speed up development in 3 year, 6 drug goal
04 Oct 2022 //
ENDPTS
TrialSpark licenses sprifermin from Merck KGaA; formation of High Line Bio
10 Jan 2022 //
PRNEWSWIRE
TrialSpark is building its own pipeline
01 Oct 2021 //
ENDPTS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.